Abstract
The proton-coupled uptake of di- and tri-peptides is the major route of dietary nitrogen absorption in the intestine and of reabsorption of filtered protein in the kidney. In addition, the transporters involved, PepT1 (SLC15a1) and PepT2 (SLC15a2), are responsible for the uptake and tissue distribution of a wide range of pharmaceutically important compounds, including β-lactam antibiotics, angiotensin-converting enzyme inhibitors, anti-cancer and anti-viral drugs. PepT1 and PepT2 are large proteins, with over 700 amino acids, and to date there are no reports of their crystal structures, nor of those of related proteins from lower organisms. Therefore there is virtually no information about the protein 3-D structure, although computer-based approaches have been used to both model the transmembrane domain (TM) layout and to produce a substrate binding template. These models will be discussed, and a new one proposed from homology modeling rabbit PepT1 to the recently crystallized bacterial transporters LacY and GlpT. Understanding the mechanism by which PepT1 and PepT2 bind and transport their substrates is of great interest to researchers, both in academia and in the pharmaceutical industries.
Similar content being viewed by others
Abbreviations
- GlpT, E.coli glycerol-3-phosphate:
-
inorganic phosphate antiporter
- hPepT1:
-
human PepT1
- LacY E.coli :
-
proton-coupled lactose permease
- rPepT1:
-
rabbit PepT1
- TM:
-
transmembrane domain
References
Abramson J., Smirnova I., Kasho V., Verner G., Kaback H.R., Iwata S. 2003. Structure and mechanism of the lactose permease of Escherichia coli. Science 301:610–615
Abramson J., Kaback H.R., Iwata S. 2004. Structural comparison of lactose permease and the glycerol-3-phosphate antiporter: members of the major facilitator superfamily. Curr. Opin. Struc. Biol. 14:413–419
Bailey P.D., Boyd C.A.R., Bronk J.R., Collier I.D., Meredith D., Morgan K.M., Temple C.S. 2000. How to make drugs orally active: a substrate template for peptide transporter PepT1. Angew. Chem. Int. Ed. 39:506–508
Bailey P.D., Boyd C.A.R., Collier I.D., George J.P., Kellett G.L., Meredith D., Morgan K.M., Pettecrew R., Price R.A. 2006. Affinity prediction for substrates of the peptide transporter PepT1. Chem. Commun. (Camb.). 2006:323–325
Bates P.A., Sternberg M.J.E. 1999. Model building by comparison at CASP3: Using expert knowledge and computer automation. Proteins: Structure, Function and Genetics, 3(Suppl):47–54
Bates P.A., Kelley L.A., MacCallum R.M., Sternberg M.J.E. 2001. Enhancement of protein modeling by human intervention in applying the automatic programs 3DJIGSAW and 3D-PSSM. Proteins: Structure, Function and Genetics, 5(Suppl):39–46
Boll M., Daniel H. 1995. Target size analysis of the peptide/H(+)-symporter in kidney brush-border membranes. Biochim. Biophys. Acta. 1233:145–152
Bolger M.B., Haworth I.S., Yeung A.K., Ann D., von Grafenstein H., Hamm-Alvarez S., Okamoto C.T., Kim K.J., Basu S.K., Wu S., Lee V.H. 1998. Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J. Pharm. Sci. 87:1286–1291
Chang A.B., Lin R., Studley W.K., Tran C.V., Saier M.H. 2004. Phylogeny as a guide to structure and function of membrane transport proteins. Mol. Membr. Biol. 21:171–181
Contreras-Moreira B., Bates P.A. 2002. Domain Fishing: a first step in protein comparative modeling. Bioinformatics 18:1141–1142
Covitz K.M., Amidon G.L., Sadee W. 1998. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions. Biochemistry 37:15214–15221
Daniel H. 2004. Molecular and integrative physiology of intestinal peptide transport. Annu. Rev. Physiol. 66:361–384
Daniel H., Kottra G. 2004. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pfluegers Arch. 447:610–618
Daniel H., Spanier B., Kottra G., Weitz D. 2006. From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology 21:93–102
Fei Y.J., Kanai Y., Nussberger S., Ganapathy V., Leibach F.H., Romero M.F., Singh S.K., Boron W.F., Hediger M.A. 1994. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368:563–566
Gebauer S., Knutter I., Hartrodt B., Brandsch M., Neubert K., Thondorf I. 2003. Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1. J. Med. Chem. 46:5725
Huang Y., Lemieux M.J., Song J., Auer M. & Wang D.N. 2003. Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301:616–620
Kaback H.R., Sahin-Toth M., Weinglass A.B. 2001. The kamikaze approach to membrane transport. Nature Rev. Mol. Cell Biol. 2:610–620
Kaback H.R. 2005. Structure and mechanism of the lactose permease. C R Biol 328:557–567
Kulkarni A.A., Haworth I.S., Lee V.H. 2003a. Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway. Biochem. Biophys. Res. Commun. 306:177–185
Kulkarni A.A., Haworth I.S., Uchiyama T., Lee V.H. 2003b. Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis. J. Biol. Chem. 278:51833–51840
Lee V.H., Chu C., Mahlin E.D., Basu S.K., Ann D.K., Bolger M.B., Haworth I.S., Yeung A.K., Wu S.K., Hamm-Alvarez S., Okamoto C.T. 1999. Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1. J. Control Release 62:129–140
McGuffin L.J., Bryson K., Jones D.T. 2000. The PSIPRED protein structure prediction server. Bioinformatics. 16:404–405
Meredith D., Boyd C.A.R. 1996. His57 is an essential residue for the transport of the anionic dipeptide D-Phe-L-Glu by PepT1 expressed in Xenopus laevis oocytes. J. Physiol. 497:89P–90P
Meredith D., Boyd C.A.R., Bronk J.R., Bailey P.D., Morgan K.M., Collier I.D., Temple C.S. 1998. 4-aminomethylbenzoic acid is a non-translocated competitive inhibitor of the epithelial peptide transporter PepT1. J. Physiol. 512:629–634
Meredith D., Boyd C.A.R. 2000. Structure and function of eukaryotic peptide transporters. Cell. Mol. Life Sci. 57:754–778
Meredith, D. 2003. Site-directed mutagenesis investigations of the substrate-binding site of the rabbit proton-coupled peptide transporter PepT1 expressed in Xenopus oocytes. J. Physiol. 549P:C7
Meredith D. 2004. Site-directed mutation of arginine 282 to glutamate uncouples the movement of peptides and protons by the rabbit proton-peptide cotransporter PepT1. J. Biol. Chem. 279:15795–15798
O’Donoghue P., Luthey-Schulten Z. 2003. Evolution of structure in aminoacyl-tRNA synthetases. Microbiol. Mol. Biol. Rev. 67:550–573
Panitsas K.E., Boyd C.A.R., Meredith D. 2006. Evidence that the rabbit proton-peptide co-transporter PepT1 is a multimer when expressed in Xenopus laevis oocytes. Pfluegers Arch. 452:53–631
Paulsen, I.T., Skurray, R.A. 1994. The POT family of transport proteins. Trends Biochem. Sci. 19:404
Pieri M., Boyd C.A.R., Meredith D. 2004. Studies on the proton coupling mechanism of the rabbit epithelial H+/peptide transporter PepT1, expressed in Xenopus oocytes. J. Physiol. 559P:C6
Pieri M., Gan C., Boyd C.A.R., Meredith D. 2005. Systematic investigation of the role of the tyrosine residues in the transmembrane regions of the rabbit proton-coupled peptide transporter, PepT1. J. Physiol. 567P:PC171
Pieri M., Boyd C.A.R., Bailey P.D., Meredith D. 2006. The functional role of tyrosine56 in the rabbit proton-peptide cotransporter, PepT1 expressed in Xenopus oocytes. Proc. Physiol. Soc. 2:PC18
Saier M.H., Tran C.V., Barabote R.D. 2006. TCDB: the Transporter Classification Database for membrane transport protein analyses and information. Nucleic Acids Res. 34:D181–D186
Terada T., Saito H., Mukai M., Inui K.I. 1996. Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1. FEBS Lett. 394:196–200
Terada & Inui T. K. 2004. Peptide transporters: structure, function, regulation and application for drug delivery. Curr. Drug. Metab. 5:85–94
Ubarretxena-Belandia I., Tate C.G. 2004. New insights into the structure and oligomeric state of the bacterial multidrug transporter EmrE: an unusual asymmetric homo-dimer. FEBS Lett. 564:234–238
Vig B.S., Stouch T.R., Timoszyk J.K., Quan Y., Wall D.A., Smith R.L., Faria T.N. 2006. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. J. Med. Chem. 49:3636–3644
Wang Y., Geer L.Y., Chappey C., Kans J.A., Bryant S.H. 2000. Cn3D: sequence and structure views for Entrez. Trends Biochem. Sci. 25:300–302
Wilson M.C., Meredith D., Fox J.E., Manoharan C., Davies A.J., Halestrap A.P. 2005. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J. Biol. Chem. 280:27213–27221
Yeung A.K., Basu S.K., Wu S.K., Chu C., Okamoto C.T., Hamm-Alvarez S.F., von Grafenstein H., Shen W.C., Kim K.J., Bolger M.B., Haworth I.S., Ann D.K., Lee V.H. 1998. Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1). Biochem. Biophys. Res. Commun. 250:103–107
Acknowledgement
We thank the Wellcome Trust for their generous support, and Professor Pat Bailey, University of Manchester, for helpful discussion.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meredith, D., Price, R. Molecular Modeling of PepT1 — Towards a Structure. J Membrane Biol 213, 79–88 (2006). https://doi.org/10.1007/s00232-006-0876-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-006-0876-6